Licensing Opportunity – Next-Generation CAR-T for Multiple Myeloma
July 8, 2025
Utrecht Holdings is proud to offer a patent-pending CAR-T cell therapy platform developed by researchers at UMC Utrecht.
Utrecht Holdings is proud to offer a patent-pending CAR-T cell therapy platform developed by researchers at UMC Utrecht.
Utrecht Holdings is the Knowledge Transfer Office for Utrecht University and UMC Utrecht.
Menu
Visiting address
Utrecht Holdings
Bestuursgebouw
Heidelberglaan 8
3584 CS Utrecht
The Netherlands
BTW-nummers (VAT numbers): UU Holding BV: NL806771604B01 || UMCU Holding BV: NL806125214B01